May 2008
Volume 49, Issue 13
Free
ARVO Annual Meeting Abstract  |   May 2008
An Epidemiological Study of Glaucoma Prevalence and Spectrum of Glaucoma Severity
Author Affiliations & Notes
  • K. L. Berenson
    Global Health Outcomes, Analytica International, New York, New York
  • P. L. Lee
    Duke University Eye Center, Durham, North Carolina
  • R. Varma
    University of Southern California, Los Angeles, California
  • J. J. Doyle
    Global Health Outcomes, Analytica International, New York, New York
  • L. R. Siegartel
    Global Health Outcomes, Analytica International, New York, New York
  • L. S. Stern
    Global Health Outcomes, Analytica International, New York, New York
  • A. Sherwood
    MedNet Solutions, Inc., Minnetonka, Minnesota
  • M. Schwartz
    MedNet Solutions, Inc., Minnetonka, Minnesota
  • J. G. Walt
    Allergan Inc., Irvine, California
  • Footnotes
    Commercial Relationships  K.L. Berenson, Allergan Inc. is client of employer, E; P.L. Lee, Allergan, C; R. Varma, Allergan, C; J.J. Doyle, Allergan Inc. is client of employer, E; L.R. Siegartel, Allergan Inc. is client of employer, E; L.S. Stern, Allergan Inc. is client of employer, E; A. Sherwood, Allergan Inc. is client of employer, E; M. Schwartz, Allergan Inc. is client of employer, E; J.G. Walt, Employee of Allergan Inc., E.
  • Footnotes
    Support  Allergan Inc.
Investigative Ophthalmology & Visual Science May 2008, Vol.49, 3602. doi:https://doi.org/
  • Views
  • Share
  • Tools
    • Alerts
      ×
      This feature is available to authenticated users only.
      Sign In or Create an Account ×
    • Get Citation

      K. L. Berenson, P. L. Lee, R. Varma, J. J. Doyle, L. R. Siegartel, L. S. Stern, A. Sherwood, M. Schwartz, J. G. Walt; An Epidemiological Study of Glaucoma Prevalence and Spectrum of Glaucoma Severity. Invest. Ophthalmol. Vis. Sci. 2008;49(13):3602. doi: https://doi.org/.

      Download citation file:


      © ARVO (1962-2015); The Authors (2016-present)

      ×
  • Supplements
Abstract
 
Purpose:
 

To determine the distribution of glaucoma severity in a community care setting in the US and to determine the agreement between patients' glaucoma stage from data collected by ophthalmologists and glaucoma stage determined by a validated glaucoma staging system based on VFL, visual acuity, and other ophthalmologic factors.

 
Methods:
 

Patients were sampled from 43 ophthalmology practices, chosen based on participation in ophthalmology registries. Patient data on factors such as demographics, risk factors, visual field test results, and IOP lowering medication use during the ophthalmologist visit were collected via case report forms. Sites enrolled 50 consecutive patients with glaucoma or ocular hypertension. Ophthalmologists staged patients using a modified Bascom Palmer scale (Mills RP, et al. Am J Ophthalmol 2006). Of the 2,296 patients sampled, visual field testing was performed between February and June 2007 on 2,092 OD and 2,097 OS. If visual field testing could not be performed the eye was considered stage 5. Kappa statistics measured agreement between physician staging and published scale.

 
Results:
 

Mean age of the sample was 68.7 years (SD=14.3); the majority were women (58.4%). Physicians staged patients less severely than the GSS, and agreement between physician stage and GSS was fair; OD Kappa: 0.5163 (95% CI: 0.4724 - 0.5603), OS Kappa: 0.4820 (95% CI: 0.4384 - 0.5256).  

 
Keywords: clinical (human) or epidemiologic studies: prevalence/incidence • visual fields 
×
×

This PDF is available to Subscribers Only

Sign in or purchase a subscription to access this content. ×

You must be signed into an individual account to use this feature.

×